| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |